SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-19-095675
Filing Date
2019-04-02
Accepted
2019-04-02 16:29:51
Documents
5
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d688243dpre14a.htm PRE 14A 703056
2 GRAPHIC g688243g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g688243g57l11.jpg GRAPHIC 8259
4 GRAPHIC g688243g58l62.jpg GRAPHIC 8894
5 GRAPHIC g688243g99y44.jpg GRAPHIC 30556
  Complete submission text file 0001193125-19-095675.txt   789510
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36167 | Film No.: 19725364
SIC: 2834 Pharmaceutical Preparations